{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:14:36Z","timestamp":1794849276871,"version":"4.9.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,5,24]],"date-time":"2015-05-24T00:00:00Z","timestamp":1432425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s40618-015-0315-6","type":"journal-article","created":{"date-parts":[[2015,5,23]],"date-time":"2015-05-23T05:45:15Z","timestamp":1432359915000},"page":"817-825","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?"],"prefix":"10.1007","volume":"38","author":[{"given":"G.","family":"Targher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,24]]},"reference":[{"key":"315_CR1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ajg.2012.128","volume":"107","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ, American Association for the Study of Liver Diseases; American College of Gastroenterology; American Gastroenterological Association (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol 107:811\u2013826","journal-title":"Am J Gastroenterol"},{"key":"315_CR2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","volume":"10","author":"QM Anstee","year":"2012","unstructured":"Anstee QM, Targher G, Day CP (2012) Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 10:330\u2013344","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"315_CR3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","volume":"47","author":"A Lonardo","year":"2015","unstructured":"Lonardo A, Ballestri S, Marchesini G, Angulo P, Loria P (2015) NAFLD a precursor of the metabolic syndrome. Dig Liv Dis 47:181\u2013190","journal-title":"Dig Liv Dis"},{"key":"315_CR4","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","volume":"59","author":"MJ Armstrong","year":"2014","unstructured":"Armstrong MJ, Adams LA, Canbay A, Syn WK (2014) Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 59:1174\u20131197","journal-title":"Hepatology"},{"key":"315_CR5","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","volume":"363","author":"G Targher","year":"2010","unstructured":"Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363:1341\u20131350","journal-title":"N Engl J Med"},{"key":"315_CR6","first-page":"544","volume":"34","author":"G Targher","year":"2011","unstructured":"Targher G, Chonchol M, Pichiri I, Zoppini G (2011) Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence? J Endocrinol Invest 34:544\u2013551","journal-title":"J Endocrinol Invest"},{"key":"315_CR7","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.3748\/wjg.v20.i7.1724","volume":"20","author":"S Ballestri","year":"2014","unstructured":"Ballestri S, Lonardo A, Bonapace S, Byrne CD, Loria P, Targher G (2014) Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World J Gastroenterol 20:1724\u20131745","journal-title":"World J Gastroenterol"},{"key":"315_CR8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2014.05.019","volume":"64","author":"G Targher","year":"2014","unstructured":"Targher G, Chonchol MB, Byrne CD (2014) CKD and nonalcoholic fatty liver disease. Am J Kidney Dis 64:638\u2013652","journal-title":"Am J Kidney Dis"},{"key":"315_CR9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2011.04038.x","volume":"75","author":"O Pirgon","year":"2011","unstructured":"Pirgon O, Bilgin H, Tolu I, Odabas D (2011) Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf) 75:189\u2013195","journal-title":"Clin Endocrinol (Oxf)"},{"key":"315_CR10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12020-012-9613-3","volume":"42","author":"RM Campos","year":"2012","unstructured":"Campos RM, de Piano A, da Silva PL, Carnier J, Sanches PL, Corgosinho FC, Masquio DC, Lazaretti-Castro M, Oyama LM, Nascimento CM, Tock L, de Mello MT, Tufik S, D\u00e2maso AR (2012) The role of pro\/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy. Endocrine 42:146\u2013156","journal-title":"Endocrine"},{"key":"315_CR11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2036.2011.04924.x","volume":"35","author":"PE Pardee","year":"2012","unstructured":"Pardee PE, Dunn W, Schwimmer JB (2012) Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children. Aliment Pharmacol Ther 35:248\u2013254","journal-title":"Aliment Pharmacol Ther"},{"key":"315_CR12","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00508-012-0211-4","volume":"124","author":"T Purnak","year":"2012","unstructured":"Purnak T, Beyazit Y, Ozaslan E, Efe C, Hayretci M (2012) The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease. Wien Klin Wochenschr 124:526\u2013531","journal-title":"Wien Klin Wochenschr"},{"key":"315_CR13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12020-012-9639-6","volume":"42","author":"SS Moon","year":"2012","unstructured":"Moon SS, Lee YS, Kim SW (2012) Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. Endocrine 42:423\u2013429","journal-title":"Endocrine"},{"key":"315_CR14","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1210\/jc.2011-3010","volume":"97","author":"M Li","year":"2012","unstructured":"Li M, Xu Y, Xu M, Ma L, Wang T, Liu Y, Dai M, Chen Y, Lu J, Liu J, Bi Y, Ning G (2012) Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese. J Clin Endocrinol Metab 97:2033\u20132038","journal-title":"J Clin Endocrinol Metab"},{"key":"315_CR15","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.3748\/wjg.v19.i25.4007","volume":"19","author":"L Pacifico","year":"2013","unstructured":"Pacifico L, Bezzi M, Lombardo CV, Romaggioli S, Ferraro F, Bascetta S, Chiesa C (2013) Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease. World J Gastroenterol 19:4007\u20134014","journal-title":"World J Gastroenterol"},{"key":"315_CR16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.atherosclerosis.2013.07.006","volume":"230","author":"SP Bhatt","year":"2013","unstructured":"Bhatt SP, Nigam P, Misra A, Guleria R, Qadar Pasha MA (2013) Independent associations of low 25-hydroxyvitamin D and high parathyroid hormonal levels with nonalcoholic fatty liver disease in Asian Indians residing in north India. Atherosclerosis 230:157\u2013163","journal-title":"Atherosclerosis"},{"key":"315_CR17","first-page":"396545","volume":"2013","author":"R Cui","year":"2013","unstructured":"Cui R, Sheng H, Rui XF, Cheng XY, Sheng CJ, Wang JY, Qu S (2013) Low bone mineral density in Chinese adults with nonalcoholic fatty liver disease. Int J Endocrinol 2013:396545","journal-title":"Int J Endocrinol"},{"key":"315_CR18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/dmrr.1135","volume":"26","author":"FJ Paula de","year":"2010","unstructured":"de Paula FJ, Horowitz MC, Rosen CJ (2010) Novel insights into the relationship between diabetes and osteoporosis. Diabetes Metab Res Rev 26:622\u2013630","journal-title":"Diabetes Metab Res Rev"},{"key":"315_CR19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jocd.2011.11.005","volume":"15","author":"S Arikan","year":"2012","unstructured":"Arikan S, Tuzcu A, Bahceci M, Ozmen S, Gokalp D (2012) Insulin resistance in type 2 diabetes mellitus may be related to bone mineral density. J Clin Densitom 15:186\u2013190","journal-title":"J Clin Densitom"},{"key":"315_CR20","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/bmt.2009.70","volume":"43","author":"GA Faulhaber","year":"2009","unstructured":"Faulhaber GA, Premaor MO, Moser Filho HL, Silla LM, Furlanetto TW (2009) Low bone mineral density is associated with insulin resistance in bone marrow transplant subjects. Bone Marrow Transpl 43:953\u2013957","journal-title":"Bone Marrow Transpl"},{"key":"315_CR21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4239\/wjd.v4.i2.31","volume":"4","author":"EA Greco","year":"2013","unstructured":"Greco EA, Francomano D, Fornari R, Marocco C, Lubrano C, Papa V, Wannenes F, Di Luigi L, Donini LM, Lenzi A, Aversa A, Migliaccio S (2013) Negative association between trunk fat, insulin resistance and skeleton in obese women. World J Diabetes 4:31\u201339","journal-title":"World J Diabetes"},{"key":"315_CR22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrd3669","volume":"11","author":"K Redlich","year":"2012","unstructured":"Redlich K, Smolen JS (2012) Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov 11:234\u2013250","journal-title":"Nat Rev Drug Discov"},{"key":"315_CR23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jcb.1202","volume":"83","author":"W Zou","year":"2001","unstructured":"Zou W, Hakim I, Tschoep K, Endres S, Bar-Shavit Z (2001) Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism. J Cell Biochem 83:70\u201383","journal-title":"J Cell Biochem"},{"key":"315_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(03)00841-2","volume":"321","author":"MS Nanes","year":"2003","unstructured":"Nanes MS (2003) Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 321:1\u201315","journal-title":"Gene"},{"key":"315_CR25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3858\/emm.2010.42.6.045","volume":"42","author":"HL Lee","year":"2010","unstructured":"Lee HL, Yi T, Woo KM, Ryoo HM, Kim GS, Baek JH (2010) Msx2 mediates the inhibitory action of TNF alpha on osteoblast differentiation. Exp Mol Med 42:437\u2013445","journal-title":"Exp Mol Med"},{"key":"315_CR26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jor.21028","volume":"28","author":"H Ochi","year":"2010","unstructured":"Ochi H, Hara Y, Tagawa M, Shinomiya K, Asou Y (2010) The roles of TNFR1 in lipopolysaccharide induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival. J Orthop Res 28:657\u2013663","journal-title":"J Orthop Res"},{"key":"315_CR27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-9255-5-10","volume":"5","author":"CA Peterson","year":"2008","unstructured":"Peterson CA, Heffernan ME (2008) Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women. J Inflamm (Lond) 5:10","journal-title":"J Inflamm (Lond)"},{"key":"315_CR28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hep.23998","volume":"53","author":"WK Syn","year":"2011","unstructured":"Syn WK, Choi SS, Liaskou E, Karaca GF, Agboola KM, Oo YH, Mi Z, Pereira TA, Zdanowicz M, Malladi P, Chen Y, Moylan C, Jung Y, Bhattacharya SD, Teaberry V, Omenetti A, Abdelmalek MF, Guy CD, Adams DH, Kuo PC, Michelotti GA, Whitington PF, Diehl AM (2011) Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Hepatology 53:106\u2013115","journal-title":"Hepatology"},{"key":"315_CR29","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2741\/4026","volume":"17","author":"R Fujisawa","year":"2012","unstructured":"Fujisawa R, Tamura M (2012) Acidic bone matrix proteins and their roles in calcification. Front Biosci 17:1891\u20131903","journal-title":"Front Biosci"},{"key":"315_CR30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1084\/jem.193.3.399","volume":"193","author":"M Ishijima","year":"2001","unstructured":"Ishijima M, Rittling SR, Yamashita T, Tsuji K, Kurosawa H, Nifuji A, Denhardt DT, Noda M (2001) Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin. J Exp Med 193:399\u2013404","journal-title":"J Exp Med"},{"issue":"suppl 121","key":"315_CR31","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/ki.2011.25","volume":"79","author":"CB Confavreux","year":"2011","unstructured":"Confavreux CB (2011) Bone: from a reservoir of minerals to a regulator of energy metabolism. Kidney Int 79(suppl 121):S14\u2013S19","journal-title":"Kidney Int"},{"key":"315_CR32","doi-asserted-by":"crossref","first-page":"e13959","DOI":"10.1371\/journal.pone.0013959","volume":"5","author":"J Chapman","year":"2010","unstructured":"Chapman J, Miles PD, Ofrecio JM, Neels JG, Yu JG, Resnik JL, Wilkes J, Talukdar S, Thapar D, Johnson K, Sears DD (2010) Osteopontin is required for the early onset of high fat diet-induced insulin resistance in mice. PLoS One 5:e13959","journal-title":"PLoS One"},{"key":"315_CR33","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00198-009-1107-7","volume":"21","author":"IC Chang","year":"2010","unstructured":"Chang IC, Chiang TI, Yeh KT, Lee H, Cheng YW (2010) Increased serum osteopontin is a risk factor for osteoporosis in menopausal women. Osteoporos Int 21:1401\u20131409","journal-title":"Osteoporos Int"},{"key":"315_CR34","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jor.20750","volume":"27","author":"OD Kennedy","year":"2009","unstructured":"Kennedy OD, Brennan O, Rackard SM, Staines A, O\u2019Brien FJ, Taylor D, Lee TC (2009) Effects of ovariectomy on bone turnover, porosity, and biomechanical properties in ovine compact bone 12\u00a0months postsurgery. J Orthop Res 27:303\u2013309","journal-title":"J Orthop Res"},{"key":"315_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejcb.2008.06.004","volume":"88","author":"P Reid","year":"2009","unstructured":"Reid P, Holen I (2009) Pathophysiological roles of osteoprotegerin (OPG). Eur J Cell Biol 88:1\u201317","journal-title":"Eur J Cell Biol"},{"key":"315_CR36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2174\/156652411795976565","volume":"11","author":"AM Bl\u00e1zquez-Medela","year":"2011","unstructured":"Bl\u00e1zquez-Medela AM, L\u00f3pez-Novoa JM, Mart\u00ednez-Salgado C (2011) Osteoprotegerin and diabetes associated pathologies. Curr Mol Med 11:401\u2013416","journal-title":"Curr Mol Med"},{"key":"315_CR37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3109\/00365513.2010.524933","volume":"70","author":"Y Yilmaz","year":"2010","unstructured":"Yilmaz Y, Yonal O, Kurt R, Oral AY, Eren F, Ozdogan O, Ari F, Celikel CA, Korkmaz S, Ulukaya E, Imeryuz N, Kalayci C, Avsar E (2010) Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease. Scand J Clin Lab Invest 70:541\u2013546","journal-title":"Scand J Clin Lab Invest"},{"key":"315_CR38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4149\/endo_2011_02_99","volume":"45","author":"P Patterson-Buckendahl","year":"2011","unstructured":"Patterson-Buckendahl P (2011) Osteocalcin is a stress-responsive neuropeptide. Endocr Regul 45:99\u2013110","journal-title":"Endocr Regul"},{"key":"315_CR39","first-page":"114","volume":"18","author":"P Pietschmann","year":"1991","unstructured":"Pietschmann P, Resch H, Krexner E, Woloszczuk W, Willvonseder R (1991) Decreased serum osteocalcin levels in patients with postmenopausal osteoporosis. Acta Med Austriaca 18:114\u2013116","journal-title":"Acta Med Austriaca"},{"key":"315_CR40","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s00198-010-1174-9","volume":"21","author":"JM Fernandez-Real","year":"2010","unstructured":"Fernandez-Real JM, Ortega F, G\u00f3mez-Ambrosi J, Salvador J, Fr\u00fchbeck G, Ricart W (2010) Circulating osteocalcin concentrations are associated with parameters of liver fat infiltration and increase in parallel to decreased liver enzymes after weight loss. Osteoporos Int 21:2101\u20132107","journal-title":"Osteoporos Int"},{"key":"315_CR41","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/00365513.2011.604427","volume":"71","author":"Y Yilmaz","year":"2011","unstructured":"Yilmaz Y, Kurt R, Eren F, Imeryuz N (2011) Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: association with ballooning degeneration. Scand J Clin Lab Invest 71:631\u2013636","journal-title":"Scand J Clin Lab Invest"},{"key":"315_CR42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/1440-1681.12063","volume":"40","author":"J Dou","year":"2013","unstructured":"Dou J, Ma X, Fang Q, Hao Y, Yang R, Wang F, Zhu J, Bao Y, Jia W (2013) Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in Chinese men. Clin Exp Pharmacol Physiol 40:282\u2013288","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"315_CR43","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/415339a","volume":"415","author":"Y Minokoshi","year":"2002","unstructured":"Minokoshi Y, Kim YB, Peroni OD, Fryer LG, M\u00fcller C, Carling D, Kahn BB (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415:339\u2013343","journal-title":"Nature"},{"key":"315_CR44","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2006-1546","volume":"92","author":"K Ebihara","year":"2007","unstructured":"Ebihara K, Kusakabe T, Hirata M, Masuzaki H, Miyanaga F, Kobayashi N, Tanaka T, Chusho H, Miyazawa T, Hayashi T, Hosoda K, Ogawa Y, DePaoli AM, Fukushima M, Nakao K (2007) Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy. J Clin Endocrinol Metab 92:532\u2013541","journal-title":"J Clin Endocrinol Metab"},{"key":"315_CR45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.metabol.2014.10.012","volume":"64","author":"SA Polyzos","year":"2015","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS (2015) Leptin in nonalcoholic fatty liver disease: a narrative review. Metabolism 64:60\u201378","journal-title":"Metabolism"},{"key":"315_CR46","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.cell.2009.06.051","volume":"138","author":"VK Yadav","year":"2009","unstructured":"Yadav VK, Oury F, Suda N, Liu ZW, Gao XB, Confavreux C, Klemenhagen KC, Tanaka KF, Gingrich JA, Guo XE, Tecott LH, Mann JJ, Hen R, Horvath TL, Karsenty G (2009) A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 138:976\u2013989","journal-title":"Cell"},{"key":"315_CR47","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.bbrc.2012.08.011","volume":"425","author":"MG Zeadin","year":"2012","unstructured":"Zeadin MG, Butcher MK, Shaughnessy SG, Werstuck GH (2012) Leptin promotes osteoblast differentiation and mineralization of primary cultures of vascular smooth muscle cells by inhibiting glycogen synthase kinase (GSK)-3b. Biochem Biophys Res Commun 425:924\u2013930","journal-title":"Biochem Biophys Res Commun"},{"key":"315_CR48","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/jbmr.545","volume":"27","author":"VE DeMambro","year":"2012","unstructured":"DeMambro VE, Maile L, Wai C, Kawai M, Cascella T, Rosen CJ, Clemmons D (2012) Insulin-like growth factor-binding protein-2 is required for osteoclast differentiation. J Bone Miner Res 27:390\u2013400","journal-title":"J Bone Miner Res"},{"key":"315_CR49","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/jbmr.65","volume":"25","author":"K Tsuji","year":"2010","unstructured":"Tsuji K, Maeda T, Kawane T, Matsunuma A, Horiuchi N (2010) Leptin stimulates fibroblast growth factor-23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D3 synthesis in leptin-deficient ob\/ob mice. J Bone Miner Res 25:1711\u20131723","journal-title":"J Bone Miner Res"},{"key":"315_CR50","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1210\/jc.2014-3199","volume":"100","author":"P Dimitri","year":"2014","unstructured":"Dimitri P, Jacques RM, Paggiosi M, King D, Walsh J, Taylor ZA, Frangi AF, Bishop N, Eastell R (2014) Leptin may play a role in bone microstructural alterations in obese children. J Clin Endocrinol Metab 100:594\u2013602","journal-title":"J Clin Endocrinol Metab"},{"key":"315_CR51","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.med.60.101107.134820","volume":"61","author":"G Musso","year":"2010","unstructured":"Musso G, Gambino R, Cassader M (2010) Emerging molecular targets for the treatment of non-alcoholic fatty liver disease. Annu Rev Med 61:375\u2013392","journal-title":"Annu Rev Med"},{"key":"315_CR52","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1074\/jbc.M114.598011","volume":"290","author":"M Ramezani-Moghadam","year":"2015","unstructured":"Ramezani-Moghadam M, Wang J, Ho V, Iseli TJ, Alzahrani B, Xu A, van der Poorten D, Qiao L, George J, Hebbard L (2015) Adiponectin reduces hepatic stellate cell migration by promoting tissue inhibitor of metalloproteinase-1 (TIMP-1) secretion. J Biol Chem 290:5533\u20135542","journal-title":"J Biol Chem"},{"key":"315_CR53","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1359\/jbmr.060707","volume":"21","author":"XH Luo","year":"2006","unstructured":"Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, Zhou HD, Liao EY (2006) Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 21:1648\u20131656","journal-title":"J Bone Miner Res"},{"key":"315_CR54","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1210\/en.2008-1639","volume":"150","author":"GA Williams","year":"2009","unstructured":"Williams GA, Wang Y, Callon KE, Watson M, Lin JM, Lam JB, Costa JL, Orpe A, Broom N, Naot D, Reid IR, Cornish J (2009) In vitro and in vivo effects of adiponectin on bone. Endocrinology 150:3603\u20133610","journal-title":"Endocrinology"},{"key":"315_CR55","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bone.2012.05.011","volume":"51","author":"QP Wang","year":"2012","unstructured":"Wang QP, Yang L, Li XP, Xie H, Liao EY, Wang M, Luo XH (2012) Effects of 17-beta-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-kB ligand. Bone 51:515\u2013523","journal-title":"Bone"},{"key":"315_CR56","doi-asserted-by":"crossref","first-page":"12542","DOI":"10.1074\/jbc.M110.152405","volume":"286","author":"Q Tu","year":"2011","unstructured":"Tu Q, Zhang J, Dong LQ, Saunders E, Luo E, Tang J, Chen J (2011) Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1. J Biol Chem 286:12542\u201312553","journal-title":"J Biol Chem"},{"key":"315_CR57","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-0031-1300957","volume":"38","author":"G Targher","year":"2012","unstructured":"Targher G, Pichiri I, Lippi G (2012) Vitamin D, thrombosis, and hemostasis: more than skin deep. Semin Thromb Hemost 38:114\u2013124","journal-title":"Semin Thromb Hemost"},{"key":"315_CR58","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.numecd.2006.04.002","volume":"17","author":"G Targher","year":"2007","unstructured":"Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, Arcaro G (2007) Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with nonalcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 17:517\u2013524","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"315_CR59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1741-7015-9-85","volume":"9","author":"I Barchetta","year":"2011","unstructured":"Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S (2011) Cavallo MG (2011) Strong association between non-alcoholic fatty liver disease (NAFLD) and low 25(OH)-vitamin D levels in an adult population with normal serum liver enzymes. BMC Med 9:85","journal-title":"BMC Med"},{"key":"315_CR60","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/met.2013.0044","volume":"11","author":"G Targher","year":"2013","unstructured":"Targher G, Scorletti E, Mantovani A, Byrne CD (2013) Nonalcoholic fatty liver disease and reduced serum vitamin D3 levels. Metab Syndr Relat Disord 11:217\u2013228","journal-title":"Metab Syndr Relat Disord"},{"key":"315_CR61","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/EJE-13-0609","volume":"170","author":"V Nobili","year":"2014","unstructured":"Nobili V, Giorgio V, Liccardo D, Bedogni G, Morino G, Alisi A, Cianfarani S (2014) Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease. Eur J Endocrinol 170:547\u2013553","journal-title":"Eur J Endocrinol"},{"key":"315_CR62","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/hep.25930","volume":"56","author":"I Barchetta","year":"2012","unstructured":"Barchetta I, Carotti S, Labbadia G, Gentilucci UV, Muda AO, Angelico F, Silecchia G, Leonetti F, Fraioli A, Picardi A, Morini S, Cavallo MG (2012) Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. Hepatology 56:2180\u20132187","journal-title":"Hepatology"},{"key":"315_CR63","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1210\/jc.2013-3507","volume":"99","author":"E Laird","year":"2014","unstructured":"Laird E, McNulty H, Ward M, Hoey L, Mc Sorley E, Wallace JM, Carson E, Molloy AM, Healy M, Casey MC, Cunningham C, Strain JJ (2014) Vitamin D deficiency is associated with inflammation in older Irish adults. J Clin Endocrinol Metab 99:1807\u20131815","journal-title":"J Clin Endocrinol Metab"},{"key":"315_CR64","first-page":"934","volume":"30","author":"B Villaggio","year":"2012","unstructured":"Villaggio B, Soldano S, Cutolo M (2012) 1,25-dihydroxyvitamin D3 down-regulates aromatase expression and inflammatory cytokines in human macrophages. Clin Exp Rheumatol 30:934\u2013938","journal-title":"Clin Exp Rheumatol"},{"key":"315_CR65","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/flgastro-2014-100432","volume":"6","author":"K Hallsworth","year":"2015","unstructured":"Hallsworth K, Thoma C, Moore S, Ploetz T, Anstee QM, Taylor R, Day CP, Trenell MI (2015) Nonalcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls. Frontline Gastroenterol 6:44\u201351","journal-title":"Frontline Gastroenterol"},{"key":"315_CR66","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bone.2014.04.009","volume":"64","author":"SF Chastin","year":"2014","unstructured":"Chastin SF, Mandrichenko O, Helbostadt JL, Skelton DA (2014) Associations between objectively measured sedentary behaviour and physical activity with bone mineral density in adults and older adults, the NHANES study. Bone 64:254\u2013262","journal-title":"Bone"},{"key":"315_CR67","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1007\/s10620-011-1722-y","volume":"56","author":"NS Choudhary","year":"2011","unstructured":"Choudhary NS, Tomar M, Chawla YK, Bhadada SK, Khandelwal N, Dhiman RK, Duseja A, Bhansali A (2011) Hepatic osteodystrophy is common in patients with noncholestatic liver disease. Dig Dis Sci 56:3323\u20133327","journal-title":"Dig Dis Sci"},{"key":"315_CR68","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF03346365","volume":"31","author":"C Santori","year":"2008","unstructured":"Santori C, Ceccanti M, Diacinti D, Attilia ML, Toppo L, D\u2019Erasmo E, Romagnoli E, Mascia ML, Cipriani C, Prastaro A, Carnevale V, Minisola S (2008) Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol. J Endocrinol Invest 31:321\u2013326","journal-title":"J Endocrinol Invest"},{"key":"315_CR69","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.clinre.2011.09.005","volume":"35","author":"A Yurci","year":"2011","unstructured":"Yurci A, Yucesoy M, Unluhizarci K, Torun E, Gursoy S, Baskol M, Guven K, Ozbakir O (2011) Effects of testosterone gel treatment in hypogonadal men with liver cirrhosis. Clin Res Hepatol Gastroenterol 35:845\u2013854","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"315_CR70","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cgh.2013.04.031","volume":"12","author":"UC Bang","year":"2014","unstructured":"Bang UC, Benfield T, Bendtsen F, Hyldstrup L, Beck Jensen JE (2014) The risk of fractures among patients with cirrhosis or chronic pancreatitis. Clin Gastroenterol Hepatol 12:320\u2013326","journal-title":"Clin Gastroenterol Hepatol"},{"key":"315_CR71","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/jgh.12695","volume":"30","author":"M Sinclair","year":"2015","unstructured":"Sinclair M, Grossmann M, Gow PJ, Angus PW (2015) Testosterone in men with advanced liver disease: abnormalities and implications. J Gastroenterol Hepatol 30:244\u2013251","journal-title":"J Gastroenterol Hepatol"},{"key":"315_CR72","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2003.11.020","volume":"126","author":"A Lonardo","year":"2004","unstructured":"Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP (2004) Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extra-hepatic disease. Gastroenterology 126:586\u2013597","journal-title":"Gastroenterology"},{"key":"315_CR73","doi-asserted-by":"crossref","first-page":"7089","DOI":"10.3748\/wjg.v20.i23.7089","volume":"20","author":"A Lonardo","year":"2014","unstructured":"Lonardo A, Adinolfi LE, Restivo L, Ballestri S, Romagnoli D, Baldelli E, Nascimbeni F, Loria P (2014) Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen. World J Gastroenterol 20:7089\u20137103","journal-title":"World J Gastroenterol"},{"key":"315_CR74","doi-asserted-by":"crossref","first-page":"e81652","DOI":"10.1371\/journal.pone.0081652","volume":"8","author":"LG Orsini","year":"2013","unstructured":"Orsini LG, Pinheiro MM, Castro CH, Silva AE, Szejnfeld VL (2013) Bone mineral density measurements, bone markers and serum vitamin D concentrations in men with chronic non-cirrhotic untreated hepatitis C. PLoS One 8:e81652","journal-title":"PLoS One"},{"key":"315_CR75","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tem.2014.11.004","volume":"26","author":"C Ohlsson","year":"2015","unstructured":"Ohlsson C, Sj\u00f6gren K (2015) Effects of the gut microbiota on bone mass. Trends Endocrinol Metab 26:69\u201374","journal-title":"Trends Endocrinol Metab"},{"key":"315_CR76","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrgastro.2013.146","volume":"10","author":"WZ Mehal","year":"2013","unstructured":"Mehal WZ (2013) The Gordian Knot of dysbiosis, obesity and NAFLD. Nat Rev Gastroenterol Hepatol 10:637\u2013644","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"315_CR77","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2012.05.004","volume":"368","author":"T Matsubara","year":"2013","unstructured":"Matsubara T, Li F, Gonzalez FJ (2013) FXR signaling in the enterohepatic system. Mol Cell Endocrinol 368:17\u201329","journal-title":"Mol Cell Endocrinol"},{"key":"315_CR78","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MOG.0000000000000156","volume":"31","author":"T Li","year":"2015","unstructured":"Li T, Chiang JY (2015) Bile acids as metabolic regulators. Curr Opin Gastroenterol 31:159\u2013165","journal-title":"Curr Opin Gastroenterol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0315-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-015-0315-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-015-0315-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T05:31:42Z","timestamp":1717911102000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-015-0315-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,24]]},"references-count":78,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["315"],"URL":"https:\/\/doi.org\/10.1007\/s40618-015-0315-6","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,24]]}}}